AstraZeneca has begun a global withdrawal of its COVID-19 vaccine.
Its vaccine, called Vaxzevria, will no longer be distributed in the European Union.
The move follows AstraZeneca admitting in a court filing that the vaccine can cause “rare side effects.”
The vaccine can cause thrombosis with thrombocytopenia syndrome (TTS), according to the filing. TTS is reportedly a rare medical condition when a person suffers from blood clots together with a low platelet count.
Instead of noting that the withdrawal was due to the side effects, the company explained that newer vaccines targeting variants have led to Vaxzevria’s decreased demand.
“As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines. This has led to a decline in demand for Vaxzervria, which is no longer being manufactured or supplied,” an AstraZeneca spokesperson said.
Rebel News reporter Avi Yemini emphasized the company’s lack of acknowledgment for the side effects, noting, “Never forget how they cancelled anyone who questioned its safety.”
